Health-related quality of life measured using EQ-5D in patients with lymphomas

[1] Chen W(2016)Cancer statistics in China, 2015 CA Cancer J Clin 66 115-132

[2] Zheng R(2013)Long-term cognitive function, neuroimaging, and quality of life in primary CNS lymphoma Neurology 81 84-92

[3] Baade PD(2010)A review of studies mapping (or cross walking) non-preference based measures of health to generic preference-based measures Heal Econ Prev Care 11 215-225

[4] Zhang S(2011)Development and preliminary testing of the new five-level version of EQ-5D (EQ-5D-5L) An Int J Qual Life Asp Treat Care Rehabil 20 1727-1736

[5] Zeng H(2016)EQ-5D scores for diabetes-related comorbidities Value Heal 19 1002-1008

[6] Bray F(2016)EQ-5D in Central and Eastern Europe: 2000–2015 Qual Life Res 25 2693-2710

[7] Jemal A(2017)International regulations and recommendations for utility data for health technology assessment Pharmacoeconomics 35 11-19

[8] Yu XQ(2016)Quality of life results from a phase 3 study of brentuximab vedotin consolidation following autologous haematopoietic stem cell transplant for persons with Hodgkin lymphoma Br J Haematol 175 860-867

[9] He J(2013)Patient-reported outcomes of cancer survivors in England 1–5 years after diagnosis: a cross-sectional survey BMJ Open 3 e002317-A449

[10] Doolittle N(2017)PCN203 - UK utility elicitation in patients with follicular lymphoma Value Heal 20 A449-3179

[1] Chen W(2016)Cancer statistics in China, 2015 CA Cancer J Clin 66 115-132

[2] Zheng R(2013)Long-term cognitive function, neuroimaging, and quality of life in primary CNS lymphoma Neurology 81 84-92

[3] Baade PD(2010)A review of studies mapping (or cross walking) non-preference based measures of health to generic preference-based measures Heal Econ Prev Care 11 215-225

[4] Zhang S(2011)Development and preliminary testing of the new five-level version of EQ-5D (EQ-5D-5L) An Int J Qual Life Asp Treat Care Rehabil 20 1727-1736

[5] Zeng H(2016)EQ-5D scores for diabetes-related comorbidities Value Heal 19 1002-1008

[6] Bray F(2016)EQ-5D in Central and Eastern Europe: 2000–2015 Qual Life Res 25 2693-2710

[7] Jemal A(2017)International regulations and recommendations for utility data for health technology assessment Pharmacoeconomics 35 11-19

[8] Yu XQ(2016)Quality of life results from a phase 3 study of brentuximab vedotin consolidation following autologous haematopoietic stem cell transplant for persons with Hodgkin lymphoma Br J Haematol 175 860-867

[9] He J(2013)Patient-reported outcomes of cancer survivors in England 1–5 years after diagnosis: a cross-sectional survey BMJ Open 3 e002317-A449

[10] Doolittle N(2017)PCN203 - UK utility elicitation in patients with follicular lymphoma Value Heal 20 A449-3179